Zhongsheng Tong
Alakaʻi o ka ʻoihana oncology umauma
Kauka lāʻau
Luna hoʻomalu o ka pepa noiʻi Masters
Lālā kūpaʻa o ke Kōmike ʻOihana Kanesa Umauma o ka Hui Kūʻē i ke Kanesa Kina
Lālā kūpaʻa o ke Kōmike Hoʻōla Lapaʻau Targeted o ka Hui Kūʻē i ke Kanesa Kina
Hope luna hoʻomalu o ka Pūʻulu ʻOihana Kanesa Umauma o ke Kōmike Oncology Geriatric o ka Hui Kina o ka Poʻe ʻElemakule
Luna Hoʻokele o ke Kōmike ʻOihana Chemotherapy Lapaʻau o ka Tianjin Anti-cancer Association
Lālā o ka lālā Oncology o ka Hui Lapaʻau ʻo Tianjin
He lālā papa hoʻoponopono ʻo ia o ka Chinese Journal of Clinical Oncology, Tianjin Pharmaceutical, Chinese Journal of Breast Disease a me ka Chinese Journal of Comprehensive Clinical Medicine
Hoʻolauna Akamai
Me ka ʻike loea i ka oncology a me ka hana lapaʻau, ʻo ia ke alakaʻi o ka ʻoihana lapaʻau kūloko no nā puʻupuʻu umauma, ʻoi aku hoʻi i ka mālama piha ʻana i ka maʻi ʻaʻai umauma. Loaʻa iā ia ka ʻike loea i ka neoadjuvant, adjuvant a me ka chemotherapy hope loa no ka maʻi ʻaʻai umauma.
